1. Home
  2. VTRS vs SNX Comparison

VTRS vs SNX Comparison

Compare VTRS & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$14.28

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Logo TD SYNNEX Corporation

SNX

TD SYNNEX Corporation

HOLD

Current Price

$164.30

Market Cap

12.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
SNX
Founded
1961
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
12.5B
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
VTRS
SNX
Price
$14.28
$164.30
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$11.83
$168.60
AVG Volume (30 Days)
8.7M
930.5K
Earning Date
02-26-2026
01-08-2026
Dividend Yield
3.35%
1.17%
EPS Growth
N/A
25.10
EPS
N/A
9.95
Revenue
$14,124,400,000.00
$62,508,086,000.00
Revenue This Year
N/A
$5.14
Revenue Next Year
$1.25
$4.18
P/E Ratio
N/A
$16.50
Revenue Growth
N/A
6.94
52 Week Low
$6.85
$92.23
52 Week High
$14.50
$167.76

Technical Indicators

Market Signals
Indicator
VTRS
SNX
Relative Strength Index (RSI) 74.35 66.26
Support Level $12.92 $157.11
Resistance Level $14.50 $166.45
Average True Range (ATR) 0.33 3.90
MACD 0.08 1.19
Stochastic Oscillator 88.72 89.59

Price Performance

Historical Comparison
VTRS
SNX

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

Share on Social Networks: